BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
This Quarter Return
+15.01%
1 Year Return
+52.22%
3 Year Return
+181.66%
5 Year Return
+959.74%
10 Year Return
–
AUM
$1.45B
AUM Growth
+$1.45B
(+4.5%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
1.03%
Top 10 Holdings %
Top 10 Hldgs %
12.09%
Holding
481
New
136
Increased
88
Reduced
93
Closed
159
Top Buys
| 1 |
NCR Voyix
VYX
|
$13.8M |
| 2 |
Stellantis
STLA
|
$13.2M |
| 3 |
Grand Canyon Education
LOPE
|
$13.1M |
| 4 |
Ryanair
RYAAY
|
$13M |
| 5 |
STMicroelectronics
STM
|
$13M |
Top Sells
| 1 |
PVH
PVH
|
$18.2M |
| 2 |
Trinseo
TSE
|
$18.1M |
| 3 |
Silicon Motion
SIMO
|
$17.6M |
| 4 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$17.5M |
| 5 |
Coeur Mining
CDE
|
$17.1M |
Sector Composition
| 1 | Healthcare | 19.95% |
| 2 | Technology | 17.14% |
| 3 | Industrials | 14.22% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Materials | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Energy Recovery
ERII
$750M
| – | – |
-475,783
| Closed | -$7.6M |
|
377
Esperion Therapeutics
ESPR
$490M
| – | – |
-74,961
| Closed | -$1.04M |
|
378
First Hawaiian
FHB
$3.2B
| – | – |
-9,745
| Closed | -$261K |
|
379
First Horizon
FHN
$11.4B
| – | – |
-23,325
| Closed | -$355K |
|
380
Fabrinet
FN
$12.1B
| – | – |
-155,004
| Closed | -$6.91M |
|
381
Glaukos
GKOS
$5.42B
| – | – |
-89,360
| Closed | -$3.37M |
|
382
Gold Resource Corp
GORO
$88.6M
| – | – |
-197,173
| Closed | -$1.46M |
|
383
Groupon
GRPN
$990M
| – | – |
-121,380
| Closed | -$12.5M |
|
384
Hanmi Financial
HAFC
$750M
| – | – |
-54,323
| Closed | -$1.43M |
|
385
H&R Block
HRB
$6.83B
| – | – |
-46,082
| Closed | -$1.07M |
|
386
Icon
ICLR
$14B
| – | – |
-15,900
| Closed | -$1.23M |
|
387
Idexx Laboratories
IDXX
$50.7B
| – | – |
-99,112
| Closed | -$11.2M |
|
388
Insteel Industries
IIIN
$734M
| – | – |
-106,741
| Closed | -$3.87M |
|
389
Illumina
ILMN
$15.2B
| – | – |
-31,868
| Closed | -$5.63M |
|
390
Innospec
IOSP
$2.13B
| – | – |
-18,121
| Closed | -$1.1M |
|
391
IQVIA
IQV
$31.4B
| – | – |
-134,751
| Closed | -$10.9M |
|
|
MZTI
392
The Marzetti Company Common Stock
MZTI
$5B
| – | – |
-46,617
| Closed | -$6.16M |
|
393
LCI Industries
LCII
$2.5B
| – | – |
-120,455
| Closed | -$11.8M |
|
394
Lexicon Pharmaceuticals
LXRX
$392M
| – | – |
-258,353
| Closed | -$4.67M |
|
395
Live Nation Entertainment
LYV
$37.6B
| – | – |
-17,290
| Closed | -$475K |
|
396
Seres Therapeutics
MCRB
$162M
| – | – |
-1,505
| Closed | -$369K |
|
397
Medifast
MED
$153M
| – | – |
-15,147
| Closed | -$572K |
|
398
Mercer International
MERC
$210M
| – | – |
-13,933
| Closed | -$118K |
|
399
Merit Medical Systems
MMSI
$5.34B
| – | – |
-55,130
| Closed | -$1.34M |
|
400
Madison Square Garden
MSGS
$4.71B
| – | – |
-1,823
| Closed | -$220K |
|